Here's a six-pack of intriguing investment ideas: A former COO of Soros Fund has joined the board of the latest growth pick from Ian Wyatt. Kevin Kennedy picks three medical stocks. Lou Dobbs reaffirms his view on Greenpoint. Donald Rowe opts for a machine vision firm. Larry McMillan picks a commodities play. And Gregory Spears selects a "bad news hedge". (For more information on these advisors, click on their photos.)
"iMERGENT (IMGG NASDAQ Bulletin Board), which provides Internet
training and services, is a turnaround situation," says Ian Wyatt’s The Growth
Report . "The firm announced the
appointment of Gary Gladstein to the board of directors. Mr. Gladstein served as the
COO of Soros Fund from 1985 to 1999. Previously, he served as CFO at
Kohlberg Kravis Roberts & Co. We believe this is an amazing announcement, especially
coming from a small company such as iMERGENT. Mr. Gladstein certainly appears to
be a whale, and his contacts in the area of finance can only help this
small and growing company reach new heights. We believe the future is bright
for IMGG, with a pending Nasdaq listing on the horizon. Our target is
$11."
Kevin Kennedy, editor of The Coolcat
Report , has added three medical
tech stocks to his list of momentum buys; each shows relative strength of 99 (out of 100)
and trades for below $15: "I-Flow (IFLO NASDAQ) designs and markets technically advanced,
low-cost ambulatory infusion systems that are redefining the standard of care by
providing life enhancing, cost-effective solutions for pain relief and infusion
therapy. LCA-Vision (LCAV NASDAQ) owns and operates 33 LasikPlus laser
vision correction facilities in the US, plus two centers in Canada and a joint
venture in Europe. Vascular Solutions (VASC NASDAQ) is an interventional medical device
company with a focus on sealing technologies."
"Earnings have been strong for the last
quarter," says Lou Dobbs in The Lou Dobbs Money Letter.
"Results from nearly all of the S&P 500 companies are now in and 86% of them
have matched or beaten targets, and profits are up roughly 10% on the quarter.
Now that’s what I call good news. One of our featured companies, GreenPoint
Financial (GPT NYSE), had record earnings this quarter. The
company issued a 15.2% dividend increase this month, and has had a total
dividend increase of 44% this year. GreenPoint’s stock also had a 3-for-2 split
this week. That’s the kind of news we all want to hear."
"In the past, we have taken bullish
positions in the CRB Index as a way of ‘playing the field’ in commodities," says
Larry McMillan in The Option Strategist. "In addition, there
is a Commodity-Related Stocks Index ($CRX) that
includes stocks such as Phelps Dodge, Newmont Mining, Alcoa, Baker Hughes, etc.,
that is designed to be a way that ‘stock traders can trade commodities as a
basket.. The $CRX stock index has been stronger than the actual commodities
since March. Buy 2 November CRB futures contracts
at 238.50 or less. We're recommending the futures because they are
more liquid than the $CRX options. However, if you prefer the $CRX index, then
buy the $CRX October 270 calls –priced at about $7; stop yourself out on a close below
236."
"There is a bull market in small-cap
security and defense companies," says Gregory Spears, editor of
The Spears Report. "Engineered Support (EASI NASDAQ)
is just such a company. It is in the business of preparing for the worst. EASI
has particular expertise in environmental engineering for both civilian and
military emergency situations. The company has developed a 150-bed prototype of
a 500-bed mobile hospital, which could be used to provide observation,
quarantine, isolation, and treatment to victims of infectious disease outbreaks,
or other natural or man-made disasters. For the six months ended 4/30/03,
revenues rose 35% to $246 million, while net income from continuing operations
rose 36% to $16.9 million. Technically, the stock has been in a beautiful
uptrend since 1992. EASI could, at the very least, function as a 'bad news
hedge’."
